MHLW Advisory Panel Backs Nexium’s Pediatric Dosages, Oral Suspension Form

    November 6, 2017
    A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on November 2 recommended approval for additional pediatric dosages and a new oral suspension formulation for AstraZeneca’s proton pump inhibitor (PPI) Nexium (esomeprazole). The Pharmaceutical Affairs and...read more